A scientific project led by Beatriz Mothe receives the Young Researchers Award from the AstraZeneca Foundation

• The project aims to contribute to the design of more universal therapies for COVID-19 with efficacy in more vulnerable groups, such as people with immunosuppression
• The awards are an initiative to promote the development and consolidation of young scientific talent in Spain

In vitro development of a new personalized therapy for patients with neurofibromatosis type 2

Researchers from the Clinical Genomics group of the Germans Trias i Pujol Research Institute (IGTP) and the Genetics Service of the Germans Trias Hospital (HUGTiP) have developed a new in vitro therapy to recover part of the function encoded by the gene NF2, which, when altered, induces the development of neurofibromatosis type 2. The study has been published in the prestigious journal Molecular Therapy Nucleic Acids.

Reformulating clinical internships: an innovative teaching approach at IGTP

The Germans Trias i Pujol Research Institute (IGTP) and the Germans Trias Hospital participate in the HEAL project, which is funded through the Erasmus+ programme. HEAL is an ambitious project aimed at reformulating the way clinical internships currently take place in hospitals.

A study of more than 750 healthcare professionals confirms that antibodies persist 17 months after having suffered from COVID-19

• Research has also confirmed that people who suffered from the disease in a serious way generate more antibodies than those who had moderate and mild effects.
• The results of this study show significant differences in the generation of antibodies between men and women on day 30 of infection and for all antibodies measured.
• This is one of the largest studies carried out to date in Catalonia, both in terms of the volume of participants and the length of follow-up.

Open doors morning for the second year of baccalaureate students of the Col·legi Cultural de Badalona

Yesterday morning, a group of second year of scientific baccalaureate students of the Col·legi Cultural de Badalona visited the IGTP. They had the opportunity to see the facilities and learn about basic research pratices.

Breaz Medical, a new spin-off of IGTP for the timely diagnosis of COPD

• Timely diagnosis is crucial to detect chronic obstructive pulmonary disease (COPD), an underdiagnosed entity in 75% of cases
• Breaz is developing a fast and precise testing device to improve the diagnosis and prognosis of this respiratory disease

A project that develops a new immunotherapy based on a monoclonal antibody to treat cancer is one of the three initiatives chosen by CaixaResearch Consolidate

A project that develops a monoclonal antibody for cancer treatment, led by the Innate Immunity Research Group at the IGTP, is one of the three selected in the CaixaResearch Consolidate call of “la Caixa” Foundation to cutting-edge innovative biomedical projects.

The IGTP organizes the VI Interhospital Conference on Genetics in Catalonia

The VI Interhospital Conference on Genetics in Catalonia was held on Monday, organized by the Germans Trias i Pujol Hospital (HUGTiP) and Research Institute (IGTP). This annual event has been a meeting point for geneticists from a variety of Catalonia's hospitals and research centres since 2017. The main problems, advances and challenges of genetics future are shared and discussed.

Study Sets the Basis for Identifying Biomarkers of Latent Malaria Vivax Infections

Using a mouse model, the research team characterized the protein profile of small vesicles secreted by liver cells, where the latent form of the parasite hides.

The IGTP hosts the EORTC Pathobiology Group (PBG) Annual Meeting

The European Organisation for Research and Treatment of Cancer (EORTC) Pathobiology Group Annual Meeting took place on October 24 and 25, organized jointly by the Catalan Institute of Oncology (ICO) and the Germans Trias i Pujol Research Institute (IGTP). Over the two-day event, a series of talks on therapies to fight cancer were held both at the IGTP facilities and online.